Related Experiment Video
Updated: Aug 10, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Pharmacy students' attitudes and perceptions toward pharmacogenomics education
Shanice Coriolan1, Nimota Arikawe2, Arden Moscati3
1Candidate 2019, Albany College of Pharmacy and Health Sciences, Albany, NY.
Summary
Final-year pharmacy students view pharmacogenomics as clinically relevant but lack confidence in applying it. More practice-based training is needed to prepare them for using pharmacogenomics in their future practice.
Area of Science:
- Pharmacy Education
- Pharmacogenomics
- Clinical Pharmacy
Background:
- Pharmacogenomics is increasingly recognized for its role in personalized medicine.
- Integrating pharmacogenomics into pharmacy curricula is crucial for future practice.
- Understanding student perceptions is key to optimizing pharmacogenomics education.
Purpose of the Study:
- To assess final-year pharmacy students' views on pharmacogenomics education.
- To evaluate student attitudes regarding the clinical importance of pharmacogenomics.
- To determine student preparedness for implementing pharmacogenomics in practice.
Main Methods:
- A 19-question survey was administered to 978 final-year pharmacy students across 8 institutions.
- The survey focused on perceptions of pharmacogenomics education, clinical relevance, and practice readiness.
- Data were collected between January and May 2017.
Main Results:
- A 35% response rate yielded 339 participants.
- 81% believed pharmacogenomics is a useful clinical tool, but only 40% found it relevant to their training.
- Nearly half received 1-3 lectures, and most felt unprepared for practice.
Conclusions:
- Student pharmacists have positive attitudes towards pharmacogenomics' clinical relevance.
- Exposure to pharmacogenomics content varied significantly among students.
- Low confidence in readiness to use pharmacogenomics in practice highlights a need for improved educational strategies, particularly practice-based training.
More Related Videos
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...